TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
INCY

Incyte Corporation

Healthcare · Biotechnology

115.30$ -1.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Incyte Corporation (INCY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 508 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size % Per share
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow INCY
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
95 94 -174 117 53 -89 21 32 199 84 156 153 270 132 -683 269 182 107 206 173 255 115 216 174 296 284 -106 307 148 148 219 -576 311 381 266 45 559 543 369 508 1,980
17 18 15 12 12 13 13 14 14 14 14 13 14 13 13 13 13 13 14 14 15 15 16 17 17 18 19 20 21 22 22 22 23 23 22 23 24 24 24 26 98
27 28 31 34 35 34 36 37 38 37 41 41 43 42 43 46 44 45 47 45 43 48 44 46 45 53 53 55 48 60 60 57 78 72 61 65 62 62 64 67 255
10 59 98 61 7.6 59 43 44 43 44 47 47 47 45 49 61 51 40 58 21 48 -419 54 87 38 96 35 22 – – – – – – – – – – – – –
31 9.3 -100 56 -2.5 -18 28 -112 103 -66 13 -18 84 -22 -73 -22 120 -97 54 -12 -16 -40 60 -115 128 126 -187 102 -91 -73 99 -153 109 84 13 -583 -60 103 -80 -282 -319
17 16 21 30 34 25 13 11 25 25 18 47 17 29 39 44 53 51 48 66 32 34 17 12 28 21 27 7.3 11 2.3 9.5 56 18 17 3.2 19 15 22 10 12 59
-10.0 -36 -139 -37 -31 -143 -29 -3.9 -18 -36 -25 -45 12 -30 -109 -43 -14 -103 -60 -49 -33 -66 -17 -12 -28 -21 -29 -7.4 -17 -155 -73 214 38 -21 1.1 -19 -47 -37 -88 -52 -225
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – 19 0.6 2.8 0.7 25 – – – – – – – – – – – –
8.4 18 34 16 658 8.2 2.6 15 2.4 9.5 15 15 3.1 30 15 69 7.8 -23 20 -10 -17 -0.6 16 -4.7 5.3 -0.6 -2.8 -0.7 -25 -0.5 -6.2 -2,005 -0.1 0.0 19 -19 0.0 0.0 -6.9 – –
0.0 0.0 0.0 0.0 0.0 0.0 – -0.2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.6 -0.6 -0.6 -0.6 -0.7 -0.7 -0.7 -0.8 -0.8 – – – – – -1.0 -1.0 -1.1 -1.2 -1.1 -1.2 -1.2 -1.2 -4.6
7.1 14 22 10 654 3.7 2.6 5.6 2.4 4.1 4.5 9.0 2.9 29 2.5 56 0.9 12 13 3.7 -19 9.0 0.1 16 -14 -2.5 4.0 13 -37 0.3 -12 -1,997 -32 20 -13 -11 -13 138 85 65 275
92 72 -291 90 676 -229 -5.1 34 184 52 136 117 286 131 -788 284 171 14 157 128 201 58 199 179 255 261 -130 310 96 -14 133 -2,359 317 384 254 13 500 643 363 521 2,027
79 79 -195 86 19 -115 8.2 22 174 59 137 106 287 102 -723 226 129 56 158 107 223 81 199 162 269 262 -133 299 137 145 209 -631 293 364 263 26 545 521 359 495 1,920

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?